Last updated: 11/07/2018 11:49:25

Paroxetine Adult Suicidality Analysis (2006 Dataset)

GSK study ID
2006-Analysis
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Paroxetine Adult Suicidality Analysis (2006 Dataset)
Trial description: Paroxetine Adult Suicidality Analysis (2006 Dataset)
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Carpenter DJ, Fong R, Horrigan JP, Barrett PS, Kraus JE, Davies JT (2006) Suicidality incidence in young adults taking paroxetine in clinical trials. Poster Presented at American Academy of Child and Adolescent Psychiatry Annual Meeting, San Diego, CA, October 2006.
Kraus JE, Carpenter DJ, Davies JT, Fong R, Barrett PS (2007) Suicidality incidence in paroxetine adult non-depression studies. Poster Presented at Anxiety Disorders Association of America Annual Meeting, St. Louis, MO, March 2007.
Kraus JE, Carpenter DJ, Davies JT, Fong R, Barrett PS (2007) Suicidality incidence in paroxetine clinical trials in adults. Poster Presented at American Psychiatric Association Annual Meeting, San Diego, CA, May 2007.
Kraus JE, Horrigan JP, Carpenter DJ, Fong R, Barrett PS, Davies JT (2006) Features of adults with suicidal behavior in clinical trials of paroxetine. Poster Presented at Institute on Psychiatric Services Annual Meeting, New York, NY, October 2006.
Thase ME, Carpenter DJ, Fong R, Kraus JE, Barrett PS, Davies JT, Duff D, Horrigan JP (2006) Suicidality in adult paroxetine depression studies. Poster Presented at American College of Neuropsychopharmacology Annual Meeting, Hollywood, FL, December 2006.
Medical condition
Depressive Disorder
Product
Compound N/A
Collaborators
Not applicable
Study date(s)
N/A to Invalid Date
Type
Not applicable
Phase
Not applicable

Participation criteria

Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable

Trial location(s)

This study does not involve prospective enrollment of participants.

Study documents

Scientific result summary
Available language(s): English

If you wish to request for full study report, please contact - [email protected]

Results overview

Not applicable

Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
Not applicable

Plain language summaries

Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website